Characterization of NLRP12 during the In Vivo Host Immune Response to Klebsiella pneumoniae and Mycobacterium tuberculosis

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Allen, Irving C ^a,b,c   McElvania TeKippe, Erin ^c   Wilson, Justin E ^a   Lich, John D ^a,d   Arthur, Janelle C ^c   Sullivan, Jonathan T ^c   Braunstein, Miriam ^c   Ting, Jenny P Y ^a,c  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b VIRGINIA MARYLAND REGIONAL COLLEGE OF VETERINARY MEDICINE   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT PROTEIN 12; PATTERN RECOGNITION RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL VIRULENCE; CELL COUNT; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE COURSE; DOWN REGULATION; ENVIRONMENTAL EXPOSURE; FEMALE; GENE; HOST PATHOGEN INTERACTION; IMMUNE RESPONSE; IN VIVO STUDY; INNATE IMMUNITY; KLEBSIELLA PNEUMONIAE; KLEBSIELLA PNEUMONIAE INFECTION; LYMPHOCYTE; MALE; MONOCYTE; MORBIDITY; MORTALITY; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NLRP12 GENE; NONHUMAN; PNEUMONIA; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; TUBERCULOSIS; WILD TYPE;

ANIMALS; BONE MARROW CELLS; DENDRITIC CELLS; IMMUNITY, INNATE; INTERLEUKIN-6; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; LUNG; MICE; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS, PULMONARY; TUMOR NECROSIS FACTOR-ALPHA;

KLEBSIELLA PNEUMONIAE; MUS; MYCOBACTERIUM TUBERCULOSIS;

EID: 84875935843     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0060842     Document Type: Article

References (49)

1. Willingham SB, Allen IC, Bergstralh DT, Brickey WJ, Huang MT, et al. (2009) NLRP3 (NALP3, Cryopyrin) facilitates in vivo caspase-1 activation, necrosis, and HMGB1 release via inflammasome-dependent and independent pathways. J Immunol 183: 2008-2015.
2. Bean AG, Roach DR, Briscoe H, France MP, Korner H, et al. (1999) Structural deficiencies in granuloma formation in TNF gene-targeted mice underlie the heightened susceptibility to aerosol Mycobacterium tuberculosis infection, which is not compensated for by lymphotoxin. J Immunol 162: 3504-3511.
3. Harton JA, Linhoff MW, Zhang J, Ting JP, (2002) Cutting edge: CATERPILLER: a large family of mammalian genes containing CARD, pyrin, nucleotide-binding, and leucine rich repeat domains. J Immunol 169: 4088-4093.
4. Akira S, Uematsu S, Takeuchi O, (2006) Pathogen recognition and innate immunity. Cell 124: 783-801.
5. Meylan E, Tschopp J, Karin M, (2006) Intracellular pattern recognition receptors in the host response. Nature 442: 39-44.
6. Ting JP, Lovering RC, Alnemri ES, Bertin J, Boss JM, et al. (2008) The NLR gene family: a standard nomenclature. Immunity 28, 285-287.
7. Schneider M, Zimmermann AG, Roberts R, Zhang L, Swanson KV, et al. (2012) NLRC3 Attenuates TLR Signaling via Modification of TRAF6 and NF-κB. Nature Immunology. Sep 13(9): 823-31.
8. Allen IC, Moore CB, Schneider M, Lei Y, Davis BK, et al. (2011) NLRX1 Protein Attenuates Inflammatory Responses to Infection by Interfering with the RIG-I-MAVS and TRAF6-NF-κB Signaling Pathways. Immunity. Jun 24 34(6): 854-865.
9. Conti BJ, Davis BK, Zhang J, O'Connor W, Williams KL, et al. (2005) CATERPILLER 16.2 (CLR16.2), a novel NBD/LRR family member that negatively regulates T cell function. J Biol Chem 280: 18375-18385.
10. Williams KL, Lich JD, Duncan JA, Reed W, Rallabhandi P, et al. (2005) The CATERPILLER protein monarch-1 is an antagonist of toll-like receptor-, tumor necrosis factor alpha-, and Mycobacterium tuberculosis-induced pro-inflammatory signals. J Biol Chem 280: 39914-39924.
11. Williams KL, Taxman DJ, Linhoff MW, Reed W, Ting JP, (2003) Cutting edge: Monarch-1: a pyrin/nucleotide-binding domain/leucine-rich repeat protein that controls classical and nonclassical MHC class I genes. J Immunol 170: 5354-5358.
12. Lich JD, Williams KL, Moore CB, Arthur JC, Davis BK, et al. (2007) Monarch-1 suppresses non-canonical NF-kappaB activation and p52 dependent chemokine expression in monocytes. J Immunol 178: 1256-1260.
13. Cui J, Zhu L, Xia X, Wang HY, Legras X, et al. (2010) NLRC5 negatively regulates the NF kappaB and type I interferon signaling pathways. Cell. 141: 483-496.
14. Allen IC, Wilson JE, Schneider M, Lich JD, Authur JC, et al. (2012) NLRP12 Functions as a Negative Regulator of Noncanonical NF-κB Signaling and Tumorigenesis during Colitis Associated Cancer. Immunity. May 25 36(5): 742-54.
15. Arthur JC, Lich JD, Ye Z, Allen IC, Gris D, et al. (2010) Cutting edge: NLRP12 controls dendritic and myeloid cell migration to affect contact hypersensitivity. J Immunol 185: 4515-4519.
16. Zaki MH, Vogel P, Malireddi RK, Body-Malapel M, Anand PK, et al. (2011) The NOD like receptor NLRP12 attenuates colon inflammation and tumorigenesis. Cancer Cell. Nov 15 20(5): 649-60.
17. Sikarwar AS, Batra HV, (2011) Prevalence of Antimicrobial Drug Resistance of Klebisella pneumonia in India. International Journal of Bioscience, Biochemistry and Bioinformatics. Sept 1(3): 211-215.
18. Rammaert B, Goyet S, Beauté J, Hem S, Te V, et al. (2012) Klebsiella pneumoniae related community-acquired acute lower respiratory infections in Cambodia: clinical characteristics and treatment. BMC Infect Dis. Jan 10 12: 3.
19. Zhao Y, Xu S, Wang L, Chin DP, Wang S, et al. (2012) National survey of drug-resistant tuberculosis in China. N Engl J Med. Jun 7 366(23): 2161-70.
20. World Health Organization. (2011) WHO Tuberculosis facts sheet. Geneva. Available at: http://www.who.int/tb/publications/factsheets/en/index.html. Accessed 2013 March 11.
21. Brassard P, Kezouh A, Suissa S, (2006) Antirheumatic drugs and the risk of tuberculosis. Clin Infect Dis. Sep 15 43(6): 717-22.
22. McElvania Tekippe E, Allen IC, Hulseberg PD, Sullivan JT, McCann JR, et al. (2010) Granuloma formation and host defense in chronic Mycobacterium tuberculosis infection requires PYCARD/ASC but not NLRP3 or caspase-1. PLoS One 5: e12320.
23. Allen IC, Pace AJ, Jania LA, Ledford JG, Latour AM, et al. (2006) Expression and function of NPSR1/GPRA in the lung before and after induction of asthma-like disease. Am J Physiol Lung Cell Mol Physiol 291: L1005-1017.
24. Kurtz S, McKinnon KP, Runge MS, Ting JP, Braunstein M, (2006) The SecA2 secretion factor of Mycobacterium tuberculosis promotes growth in macrophages and inhibits the host immune response. Infect Immun 74: 6855-6864.
25. Allen IC, Scull MA, Moore CB, Holl EK, McElvania-TeKippe E, et al. (2009) The NLRP3 inflammasome mediates in vivo innate immunity to influenza A virus through recognition of viral RNA. Immunity 30: 556-565.
26. Wang L, Manji GA, Grenier JM, Al-Garawi A, Merriam S, et al. (2002) PYPAF7, a novel PYRIN-containing Apaf1-like protein that regulates activation of NF-kappa B and caspase-1-dependent cytokine processing. J Biol Chem 277: 29874-29880.
27. Vladimer GI, Weng D, Paquette SW, Vanaja SK, Rathinam VA, et al. (2012) The NLRP12 Inflammasome recognizes Yersinia pestis. Immunity 37(1): 96-107.
28. Simpson A, Martinez FD, (2010) The role of lipopolysaccharide in the development of atopy in humans. Clin Exp Allergy. Feb 40(2): 209-23.
29. Matute-Bello G, Frevert CW, Martin TR, (2008) Animal models of acute lung injury. Am J Physiol Lung Cell Mol Physiol 295: L379-399.
30. He X, Mekasha S, Mavrogiorgos N, Fitzgerald KA, Lien E, et al. (2010) Inflammation and fibrosis during Chlamydia pneumoniae infection is regulated by IL-1 and the NLRP3/ASC inflammasome. J Immunol 184: 5743-5754.
31. Sutterwala FS, Mijares LA, Li L, Ogura Y, Kazmierczak BI, et al. (2007) Immune recognition of Pseudomonas aeruginosa mediated by the IPAF/NLRC4 inflammasome. J Exp Med. Dec 24 204(13): 3235-45.
32. Ceballos-Olvera I, Sahoo M, Miller MA, Del Barrio L, Re F, (2011) Inflammasome dependent pyroptosis and IL-18 protect against Burkholderia pseudomallei lung infection while IL-1β is deleterious. PLoS Pathog. Dec 7(12): e1002452.
33. Theivanthiran B, Batra S, Balamayooran G, Cai S, Kobayashi K, et al. (2012) NOD2 Signaling Contributes to Host Defense in the Lungs against Escherichia coli Infection. Infect Immun. Jul 80(7): 2558-69.
34. Mayer-Barber KD, Barber DL, Shenderov K, White SD, Wilson MS, et al. (2010) Caspase 1 independent IL-1beta production is critical for host resistance to mycobacterium tuberculosis and does not require TLR signaling in vivo. J Immunol. Apr 1 184(7): 3326-30.
35. Kindler V, Sappino AP, Grau GE, Piguet PF, Vassalli P, (1989) The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection. Cell 56: 731-740.
36. Zhang Y, Broser M, Rom WN (1994) Activation of the interleukin 6 gene by Mycobacterium tuberculosis or lipopolysaccharide is mediated by nuclear factors NF-IL6 and NF-kappa B. Proc Natl Acad Sci U S A 91, 2225-2229.
37. Yamada H, Mizuno S, Reza-Gholizadeh M, Sugawara I, (2001) Relative importance of NF-kappaB p50 in mycobacterial infection. Infect Immun. Nov 69(11): 7100-5.
38. Cai S, Batra S, Shen L, Wakamatsu N, Jeyaseelan S, (2009) Both TRIF- and MyD88 dependent signaling contribute to host defense against pulmonary Klebsiella infection. J Immunol. Nov 15;1 83(10): 6629-38.
39. Souvannavong V, Saidji N, Chaby R, (2007) Lipopolysaccharide from Salmonella entericactivates NF-kappaB through both classical and alternative pathways in primary BLymphocytes. Infect Immun. Oct 75(10): 4998-5003.
40. Soysa NS, Alles N, Takahashi M, Aoki K, Ohya K, (2011) Defective nuclear factor-κB inducing kinase in aly/aly mice prevents bone resorption induced by local injection of lipopolysaccharide. J Periodontal Res. Apr 46(2): 280-4.
41. Allen IC, Lich JD, Arthur JC, Jania CM, Roberts RA, et al. (2012) Characterization of NLRP12 during the Development of Allergic Airway Disease in Mice. PLoS One. Jan 7(1): e30612.
42. Carlsson F, Kim J, Dumitru C, Barck KH, Carano RA, et al. (2010) Host-detrimental role of Esx-1-mediated inflammasome activation in mycobacterial infection. PLoS Pathog 6: e1000895.
43. Mishra BB, Moura-Alves P, Sonawane A, Hacohen N, Griffiths G, et al. (2010) Mycobacterium tuberculosis protein ESAT-6 is a potent activator of the NLRP3/ASC inflammasome. Cell Microbiol 12, 1046-1063.
44. Dorhoi A, Nouailles G, Jörg S, Hagens K, Heinemann E, et al. (2012) Activation of the NLRP3 inflammasome by Mycobacterium tuberculosis is uncoupled from susceptibility to active tuberculosis. Eur J Immunol. 2012 Feb 42(2): 374-84.
45. Rao KM, Meighan T, (2006) Exposure in vivo to silica or lipopolysaccharide produces transient or sustained upregulation, respectively, of PYPAF7 and MEFV genes in bronchoalveolar lavage cells in rats. J Toxicol Environ Health A 69: 481-490.
46. Benko S, Magalhaes JG, Philpott DJ, Girardin SE, (2010) NLRC5 limits the activation of inflammatory pathways. J Immunol 185: 1681-1691.
47. Cui J, Zhu L, Xia X, Wang HY, Legras X, et al. (2010) NLRC5 negatively regulates the NF-kappaB and type I interferon signaling pathways. Cell 141: 483-496.
48. Tong Y, Cui J, Li Q, Zou J, Wang HY, Wang RF, (2012) Enhanced TLR-induced NF κB signaling and type I interferon responses in NLRC5 deficient mice. Cell Res. May 22(5): 822-35.
49. Kumar H, Pandey S, Zou J, Kumagai Y, Takahashi K, et al. (2011) NLRC5 deficiency does not influence cytokine induction by virus and bacteria infections. J Immunol. Jan 15 186(2): 994-1000.